John Downey is the CEO of MonoBiologics, an emerging leader in single-use hardware and polymer systems for pharmaceutical and bioprocess manufacturing. The company develops innovative products that push the boundaries of what’s possible in modern drug production – improving reliability, precision, and overall process performance.

With a background in mechanical and manufacturing engineering, John brings a technical edge to MonoBiologics’ product development, leading teams that focus on the details that matter most. The company’s designs aim not only to simplify complex bioprocessing challenges but to set new standards in how single-use technology supports the creation of next-generation therapeutics.

At MonoBiologics, the mission is clear: to deliver smarter, more advanced tools that enable better science, more efficient manufacturing, and a more sustainable future for the biopharmaceutical industry in a rapidly growing area.